Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 May 2025 for Edwards Lifesciences Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Paul A. Laviolette: trading record in brief
Paul A. Laviolette (board member) discloses dealings in 3 companies, chiefly Edwards Lifesciences Corp, Asensus Surgical, Inc. and Misonix Inc. Between 5 May 2021 and 9 May 2025, the trades on record add up to 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 9 May 2025: a share grant, in Edwards Lifesciences Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul A. Laviolette
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,528 shares0Common StockSEC:0001225208-25-004953:0
3,055 shares0Common StockSEC:0001225208-24-005895:0
2,803 shares0Common StockSEC:0001225208-23-005907:0
2,300 shares0Common StockSEC:0001225208-22-006589:0
1,744,017 sharesCommon StockSEC:0001493152-21-030847:0
13,846 shares0Common StockSEC:0001209191-21-045181:0
2,615 shares0Common StockSEC:0001225208-21-007761:0
7 of 7 declarations
